Cargando…

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Jiménez-Brítez, Gustavo, Ruiz, Pablo, Soler, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346781/ https://www.ncbi.nlm.nih.gov/pubmed/32718713 http://dx.doi.org/10.1016/j.medcli.2020.07.001

Ejemplares similares

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results
por: Sánchez-Martínez, Francesca, et al.
Publicado: (2021)

Tocilizumab as a possible cause of ischemic colitis()
por: Forneiro Pérez, Rocío, et al.
Publicado: (2021)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

Glucose-6-Phosphate Dehydrogenase Deficiency: A Single-Center Experience
por: Al-Mendalawi, Mahmood D.
Publicado: (2022)

TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE
por: Poon, Joseph, et al.
Publicado: (2020)

Primary Cutaneous Lymphomas in Pediatric Age Group: Experience of a Single Dermatology Center
por: Baykal, Can, et al.
Publicado: (2023)

Transfer support and coordination of critical patients during the COVID-19 pandemic by a regional command center
por: Trenado Alvarez, J., et al.
Publicado: (2023)

Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case()
por: Gonzálvez Guardiola, Paula, et al.
Publicado: (2021)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Efficacy of Tocilizumab in COVID-19: Single-Center Experience
por: Kaya, Safak, et al.
Publicado: (2021)

Tracheotomy in patients COVID-19: A necessary high risk procedure. Two center experience()
por: Martínez-Téllez, Elisabeth, et al.
Publicado: (2020)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study()
por: Bermúdez-Ruiz, María del Carmen, et al.
Publicado: (2023)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Echocardiographic findings in critical patients with COVID-19
por: Rodríguez-Santamarta, Miguel, et al.
Publicado: (2020)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Parastomal Hernia Repair: a Single Center Experience
por: Pastor, Danielle M., et al.
Publicado: (2009)

Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients
por: Xiong, Xiaoming, et al.
Publicado: (2021)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series
por: Bordas-Martinez, Jaume, et al.
Publicado: (2021)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
por: Schmidt, Wiktor, et al.
Publicado: (2023)

Le tocilizumab, un plus dans la Covid-19 sévère
por: Dalmat, Yann-Mickael
Publicado: (2022)

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience
por: Karimi, Mehran, et al.
Publicado: (2021)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

Outcome of COVID-19 patients with use of Tocilizumab: A single center experience
por: Zain Mushtaq, Muhammad, et al.
Publicado: (2020)

A single-center experience in use of tocilizumab in COVID-19 pneumonia in India
por: Joshi, Aditya, et al.
Publicado: (2021)

D-dimer and right ventricular abnormalities as prognostic factors in critically ill COVID-19 patients
por: Gonzalez-Fernandez, Oscar, et al.
Publicado: (2020)

A case of CLIPPERS syndrome responsive to tocilizumab
por: Rempe, Torge, et al.
Publicado: (2019)

Does Airway T2 Inflammation Increase the Severity of Bronchial Hyperresponsiveness?
por: Jiménez-Gómez, Miguel, et al.
Publicado: (2023)

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

The Laparoscopic Approach in Abdominal Emergencies: A Single-Center 10-Year Experience
por: Agresta, Ferdinando, et al.
Publicado: (2004)

COVID-19 lockdown influence in the psychiatric emergencies: Drastic reduction and increase in severe mental disorders
por: Carrasco, Juan Pablo, et al.
Publicado: (2021)

COVID-19 lockdown influence in the psychiatric emergencies: Drastic reduction and increase in severe mental disorders
por: Carrasco, Juan Pablo, et al.
Publicado: (2021)

Face Mask Exemptions, Respiratory Patients, and COVID-19 in Spain. Data From the 2021 ITC EUREST-PLUS Spain Survey
por: Soriano, Joan B., et al.
Publicado: (2022)

Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
por: Gokhale, Yojana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i7nqroa199tl9pb1q7g23mk7as